Glycon M 50/500mg Tablet

Glycon M 50/500mg Tablet is a combination medication containing two active ingredients: Sitagliptin & Metformin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, while Metformin is a biguanide antidiabetic medication. This combination is prescribed for the management of type 2 diabetes mellitus to help control blood sugar levels.

Uses:

Glycon M 50/500mg Tablet is used for the treatment of type 2 diabetes mellitus in adults. Sitagliptin works by increasing the levels of incretin hormones, which stimulate insulin release and decrease glucagon secretion, thereby reducing blood sugar levels. Metformin works by decreasing hepatic glucose production, increasing insulin sensitivity, and improving glucose uptake in peripheral tissues.

Dosage:

The dosage of Glycon M 50/500mg Tablet is determined by the healthcare provider based on factors such as the patient’s medical history, renal function, and blood sugar levels. It is usually taken orally with meals to reduce gastrointestinal side effects. The recommended starting dose is typically one tablet twice daily, with gradual titration based on response and tolerance. Patients should follow the prescribed dosage and administration instructions provided by their healthcare provider.

Side Effects:

Common side effects associated with Glycon M 50/500mg Tablet may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, or abdominal discomfort. These side effects are usually mild and transient, especially when the medication is taken with food. In some cases, more serious side effects such as lactic acidosis, hypoglycemia, or allergic reactions may occur. Patients should report any adverse reactions to their healthcare provider promptly.

Precautions:

Before using Glycon M 50/500mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. It is essential to use caution in patients with renal impairment or hepatic dysfunction, as Metformin can accumulate and increase the risk of lactic acidosis. This combination medication may interact with other drugs, so it’s crucial to review the patient’s medication regimen to prevent potential interactions.

When Not to Use:

Glycon M 50/500mg Tablet is contraindicated in patients with a known hypersensitivity to Sitagliptin, Metformin, or any other components of the medication. It should not be used in patients with severe renal impairment, acute or chronic metabolic acidosis, or diabetic ketoacidosis. Additionally, this combination medication is not recommended for use in pediatric patients without the guidance of a healthcare provider.